According to FutureWise analysis the market for Cryptococcal Antigen Lateral Flow Assay in 2023 is US$ 0.74 billion, and is expected to reach US$ 1.01 billion by 2031 at a CAGR of 3.95%.
Cryptococcal antigen lateral flow assays are immunochromatography tests used to identify capsular polysaccharide antigens of cryptococcus species present in serum and Cerebrospinal Fluid (CSF). The combination of immunoassay and chromatography has revolutionized point-of-care diagnosis of cryptococcal fungi. Through one strip of the lateral flow assay, the patient is able to monitor the presence of fungal infection. This test is gaining popularity among major hospitals. North America and Europe, due to their simple operating procedure compared to other assay techniques. Furthermore, the high accuracy and sensitivity as well as the short lead time to produce results offer opportunities for early stage product development.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Cryptococcal Antigen Lateral Flow Assay Test Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Cryptococcal Antigen Lateral Flow Assay Test Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.